Know Your Investor (May Edition): Alexandria Venture Investment

Shots:In the May Edition of the Know Your Investor series, we are focussing on Alexandria Venture Investments, an integral part of Alexandria Real Estate EquitiesIn 2023, Alexandria Venture Investments invested in 24 companies; 5, 8, 5 & 6 every quarter across 2023 respectivelyFor a detailed report on all the investments, reach out…

ByPrince GiriMay 28, 2024

TOP 20

Top 20 Diagnostic Companies of 2024 

Shots:  Propelled by unceasing innovations and inch-perfect precision, the diagnostic industry is advancing at an astonishing pace In 2023, the global diagnostic test market size was valued at $210.58B and is envisioned to reach $284.38B by 2033, registering a CAGR of 3.05 percent from 2024 to 2033. Roche reclaims its first position with a revenue…

ByPrince GiriMay 23, 2024

TOP 20

Top 20 Medical Device Companies of 2024 

Shots:  Bringing innovation and technology to healthcare, the MedTech sector is growing rapidly and transforming the ways diagnosis and treatment are received With a global market size of $503.2B in 2023, the MedTech sector anticipates reaching $776.4B by 2033 with a CAGR of 4.4 percent. With a staggering revenue of $32.31B, Medtronic ranks first in…

ByPrince GiriMay 9, 2024

TOP 20

Top 20 RNAi Therapeutic Companies of 2024

Shots: RNAi therapeutics are innovative medications that enable rapid identification of specific inhibitors of disease targets across a wide range of molecule classes. Several biopharma companies are investing in RNAi therapeutics extravagantly to maintain a healthy foothold in innovative medicines In 2023, the global RNAi drug delivery market size was valued at $84.1B and is…

ByPrince GiriApril 25, 2024

INSIGHTS+

Know Your Investor (April Edition): OrbiMed Advisors

Shots:An American investment firm, OrbiMed Advisor is a prominent name when it comes to healthcare investments. The company boasts a robust portfolio of more than 180 companies, including AbCellera, Acelyrin, Actus Medical, and Adaptive Biotechnologies, among othersIn 2023, OrbiMed invested in 38 funding rounds; 11, 6, 9 & 12 every quarter across 2023…

ByPrince GiriApril 24, 2024

TOP 20

Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value

Shots: Sticking to M&A and licensing agreements can be really challenging, especially when dealing with stringent antitrust laws and evolving regulatory challenges. In such adverse scenarios, the rational and right step seems to be nullifying the existing deals.In 2023, the termination of the deal between Janssen and Arrowhead remained the talk of the town…

ByPrince GiriApril 18, 2024

TOP 20

Top 20 Biopharma Companies of 2024

Shots:Driven by innovations and propelled by the pursuit of delivering the best-in-class therapies, 2023 remained a good year for the Biopharma Industry, despite a slight revenue decline, partly due to the conclusion of the COVID-19 pandemicWith a CAGR of 7.8 %, the global biopharma industry is anticipated to register a market size of…

ByPrince GiriApril 11, 2024

TOP 20

Top 20 IPOs in Healthcare by Total Fund Value 2023

Shots:Clinical-stage biopharma companies are in constant need of funding and the best way to pull in money in such dire situations is by going public. 2023 had been a great year for Wall Streets across the globe with continuous announcements of IPOsKenvue by bagging $4.37B upon completion of its IPO ranked first in…

ByPrince GiriMarch 28, 2024

TOP 20

Top 20 Women Health Focusing Companies of 2024 Based on Market Cap

Shots:While the World celebrated International Women’s Day, PharmaShots was busy preparing an exciting report on the Top 20 Women Health Focusing Companies Based on Market CapWomen's Health Market size was valued at $38.10B in 2023 and is expected to register $58.10B by 2030 with a CAGR of 4.9 percent. AbbVie managed to secure…

ByPrince GiriMarch 14, 2024

TOP 20

Top 20 Radiopharma Companies of 2024 Based on Market Cap

Shots:With diverse applications in diagnostic imaging, theragnostics, and targeted therapy, radiopharmaceuticals are gradually tapping into an ocean of unlimited opportunitiesBy 2030, the radiopharmaceutical market size is expected to grow to $12.18B. In 2023, POINT Biopharma topped the list among radiopharma companies with a market cap of $726.88B followed by Novartis with a market…

ByPrince GiriFebruary 28, 2024

Prince Giri

Know Your Investor (May Edition): Alexandria Venture Investment

Top 20 Diagnostic Companies of 2024

Top 20 Medical Device Companies of 2024

Top 20 RNAi Therapeutic Companies of 2024

Know Your Investor (April Edition): OrbiMed Advisors

Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value

Top 20 Biopharma Companies of 2024

Top 20 IPOs in Healthcare by Total Fund Value 2023

Top 20 Women Health Focusing Companies of 2024 Based on Market Cap

Top 20 Radiopharma Companies of 2024 Based on Market Cap

Contact US

OUR INFORMATION

FOLLOW US